We are live on ! Find out more
SFM

Soros Fund Management Portfolio holdings

AUM $9.12B
1-Year Est. Return 30.69%
This Fund
S&P 500
This Quarter Est. Return
+2.35%
1 Year Est. Return
+30.69%
3 Year Est. Return
+70.05%
5 Year Est. Return
+69.93%
10 Year Est. Return
+534.14%
AUM
$5.57B
AUM Growth
-$450M
Cap. Flow
-$1.24B
Cap. Flow %
-22.36%
Top 10 Hldgs %
31.38%
Holding
243
New
57
Increased
46
Reduced
30
Closed
66

Sector Composition

Rank Sector Weight
1 Healthcare 13.87%
2 Consumer Discretionary 9.48%
3 Industrials 8.1%
4 Technology 6.17%
5 Communication Services 5.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RUN icon
76
Sunrun
RUN
$2.56B
$15.1M 0.27%
1,274,741
-806,200
-39% -$9.87M
CFLT
77
CALL
DELISTED
Confluent
CFLT
$14.8M 0.27%
500,000
-1,122,600
-69% -$32.3M
ALL icon
78
Allstate
ALL
$67.2B
$14.6M 0.26%
91,470
-16,100
-15% -$2.69M
BL icon
79
CALL
BlackLine
BL
$1.91B
$14.5M 0.26%
+300,000
New +$16.5M
SWTX
80
DELISTED
SpringWorks Therapeutics
SWTX
$14.5M 0.26%
385,000
+181,054
+89% +$7.62M
AME icon
81
Ametek
AME
$56.9B
$13.9M 0.25%
83,255
+9,921
+14% +$1.71M
ASND icon
82
Ascendis Pharma A/S
ASND
$15.8B
$13.6M 0.25%
100,000
+96,568
+2,814% +$13.1M
NSC icon
83
Norfolk Southern
NSC
$76.1B
$13.3M 0.24%
62,161
+18,573
+43% +$4.31M
A icon
84
Agilent Technologies
A
$39B
$13M 0.23%
+100,000
New +$14M
LQD icon
85
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$33B
$12.9M 0.23%
120,734
-124,266
-51% -$13.3M
BMRN icon
86
BioMarin Pharmaceuticals
BMRN
$11.7B
$12.8M 0.23%
156,053
+153
+0.1% +$12.7K
UNH icon
87
UnitedHealth
UNH
$371B
$12.7M 0.23%
+25,001
New +$12.3M
CARR icon
88
Carrier Global
CARR
$53.7B
$12.3M 0.22%
195,730
+111,014
+131% +$6.82M
MKSI icon
89
MKS Inc
MKSI
$21.8B
$11.2M 0.2%
+85,914
New +$10.8M
ISRG icon
90
Intuitive Surgical
ISRG
$129B
$11.1M 0.2%
25,000
-12,500
-33% -$4.98M
JPM icon
91
JPMorgan Chase
JPM
$961B
$11M 0.2%
54,600
+20,100
+58% +$3.93M
NTRA icon
92
Natera
NTRA
$39B
$10.8M 0.19%
100,000
+35,000
+54% +$3.56M
TECK icon
93
Teck Resources
TECK
$31.3B
$10.8M 0.19%
225,500
-387,952
-63% -$19.1M
LOAR icon
94
Loar Holdings
LOAR
$6.89B
$10.7M 0.19%
+200,000
New +$10.8M
MCHP icon
95
Microchip Technology
MCHP
$43B
$10.5M 0.19%
+114,800
New +$10.5M
PRVA icon
96
Privia Health
PRVA
$2.99B
$10.4M 0.19%
600,000
+375,000
+167% +$6.64M
HCP
97
CALL
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$10.1M 0.18%
+300,000
New +$9.33M
ATI icon
98
ATI
ATI
$27B
$9.82M 0.18%
+177,047
New +$9.92M
EXAS
99
DELISTED
Exact Sciences
EXAS
$9.51M 0.17%
+225,000
New +$12.4M
DD icon
100
DuPont de Nemours
DD
$18.8B
$9.37M 0.17%
92,704
+34,703
+60% +$3.4M

Similar funds

Soros Fund Management's Q2 2024 Portfolio in Review

As of Q2 2024, Soros Fund Management held 243 positions worth $5.57B, down 7.5% from $6.02B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Soros Fund Management withdrew a net $1.24B in Q2 2024, closing 66 positions and reducing 30 holdings. Its most notable exit was American Equity Investment Life Holding Company, an estimated $108M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 7.6% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Soros Fund Management opened a new position in State Street SPDR S&P 500 ETF Trust worth $245M.

  • Soros Fund Management's largest Q2 2024 buy was State Street SPDR S&P 500 ETF Trust: 450,000 shares worth $245M.
  • Soros Fund Management added most to AstraZeneca in Q2 2024, an estimated $154M increase.
  • Soros Fund Management's biggest Q2 2024 reduction was Alphabet (Google) Class A, cutting an estimated $97M.
  • Soros Fund Management fully exited American Equity Investment Life Holding Company in Q2 2024, selling an estimated $108M.
  • Soros Fund Management's ten largest holdings make up 31% of its $5.57B portfolio in Q2 2024.
  • Soros Fund Management opened 57 new positions and closed 66 in Q2 2024.
  • Soros Fund Management's portfolio value fell 7.5% quarter-over-quarter to $5.57B.

Based on Soros Fund Management's 13F filing for Q2 2024, filed 14 Aug 2024.